UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal of the American Heart Association, 2018-12, Vol.7 (24), p.e011245

2018

Volltextzugriff (PDF)

Kombination von nab‐Paclitaxel und Radiotherapie bei großem kutanen Angiosarkom an Gesicht und Kopfhaut mit Lungenmetastasen

Journal der Deutschen Dermatologischen Gesellschaft, 2020-07, Vol.18 (7), p.754-757

2020

Volltextzugriff (PDF)

Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer

Biomaterials, 2017-09, Vol.140, p.162-169

2017

Volltextzugriff (PDF)

Albumin-bound paclitaxel in solid tumors: clinical development and future directions

Drug design, development and therapy, 2015, Vol.9 (default), p.3767-3777

2015

Volltextzugriff (PDF)

Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy

Nano letters, 2018-06, Vol.18 (6), p.3643-3650

2018

Volltextzugriff (PDF)

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

The New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158

2023

Volltextzugriff (PDF)

Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells

Journal of controlled release, 2015-12, Vol.220 (Pt B), p.727-737

2015

Volltextzugriff (PDF)

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies

Circulation (New York, N.Y.), 2017-09, Vol.136 (12), p.1102-1113

2017

Volltextzugriff (PDF)

Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel

Journal of controlled release, 2013-02, Vol.166 (1), p.66-74

2013

Volltextzugriff (PDF)

Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery

Biomaterials, 2011-11, Vol.32 (31), p.8010-8020

2011

Volltextzugriff (PDF)

Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells

Nanomedicine, 2016-04, Vol.12 (3), p.655-664

2016

Volltextzugriff (PDF)

Medikamentenbeschichtete Ballons bei PAVK

Deutsche medizinische Wochenschrift, 2022-09, Vol.147 (17), p.1091-1096

2022

Volltextzugriff (PDF)

Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics

International journal of nanomedicine, 2020-01, Vol.15, p.8331-8343

2020

Volltextzugriff (PDF)

nab-Paclitaxel mechanisms of action and delivery

Journal of controlled release, 2013-09, Vol.170 (3), p.365-372

Yardley, Denise A.

2013

Volltextzugriff (PDF)

Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)–paclitaxel nanoconjugates

Journal of colloid and interface science, 2017-03, Vol.490, p.783-796

2017

Volltextzugriff (PDF)

Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment

Biomaterials, 2013-11, Vol.34 (33), p.8511-8520

2013

Volltextzugriff (PDF)

Albumin-bound paclitaxel: a next-generation taxane

Expert opinion on pharmacotherapy, 2006-06, Vol.7 (8), p.1041-1053

Gradishar, William J

2006

Volltextzugriff (PDF)

An Imagable and Photothermal "Abraxane-Like" Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast Tumors

Advanced materials (Weinheim), 2015-02, Vol.27 (5), p.903-910

2015

Volltextzugriff (PDF)

Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release

Journal of the American Chemical Society, 2018-06, Vol.140 (24), p.7373-7376

2018

Volltextzugriff (PDF)

Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo

Biomaterials, 2016-04, Vol.84, p.250-261

2016

Volltextzugriff (PDF)

Paclitaxel: What has been done and the challenges remain ahead

International journal of pharmaceutics, 2017-06, Vol.526 (1-2), p.474-495

2017

Volltextzugriff (PDF)

Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus®—Solutol® HS15 binary mixed micelles system

International journal of pharmaceutics, 2016-10, Vol.512 (1), p.186-193

2016

Volltextzugriff (PDF)

Phase II study of nab‐paclitaxel + carboplatin for patients with non‐small‐cell lung cancer and interstitial lung disease

Cancer science, 2019-12, Vol.110 (12), p.3738-3745

2019

Volltextzugriff (PDF)

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

British journal of cancer, 2005-04, Vol.92 (7), p.1240-1246

2005

Volltextzugriff (PDF)

Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform

International journal of pharmaceutics, 2014-01, Vol.460 (1-2), p.131-143

2014

Volltextzugriff (PDF)

1 – 25 von 35.084

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(30.120)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(29.648)
Life Sciences & Biomedicine
(26.896)
Humans
(24.147)
Paclitaxel
(17.256)
Female
(15.236)
Oncology
(13.066)
Paclitaxel - Administration & Dosage
(12.093)
Middle Aged
(9.046)
Chemotherapy
(9.001)
Male
(7.933)
Aged
(7.894)
Biological And Medical Sciences
(7.706)
Paclitaxel - Pharmacology
(7.385)
Animals
(7.218)
Medical Sciences
(7.066)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7.049)
Adult
(6.093)
Paclitaxel - Therapeutic Use
(5.535)
Pharmacology & Pharmacy
(5.311)
Treatment Outcome
(4.982)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(28.484)
IngentaConnect
(18.323)
EZB Electronic Journals Library
(16.519)
Journals@Ovid Ovid Full Text
(12.168)
IngentaConnect Journals
(9.543)
Elsevier ScienceDirect Journals Complete
(8.151)
NUS Single-Journal Subscriptions
(6.413)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(5.549)
Springer Journals
(4.738)
Wiley Online Library - AutoHoldings Journals
(4.063)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(3.278)
Wiley Online Library
(2.685)
Taylor & Francis Journals Auto-Holdings Collection
(1.692)
Springer Nature - Connect here FIRST to enable access
(1.358)
Taylor & Francis
(1.340)
Taylor & Francis Journals Complete
(1.093)
Nexis Uni
(986)
Oxford Journals
(704)
SAGE Journals
(683)
Oxford Journals 2020 Medicine
(502)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Gan To Kagaku Ryoho
(803)
Journal Of Clinical Oncology
(778)
Gynecologic Oncology
(696)
Seminars In Oncology
(586)
Annals Of Oncology
(549)
Anticancer Research
(549)
Cancer Chemotherapy And Pharmacology
(503)
Clinical Cancer Research
(503)
Plos One
(423)
Cancer
(384)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Kombination von nab‐Paclitaxel und Radiotherapie bei großem kutanen Angiosarkom an Gesicht und Kopfhaut mit Lungenmetastasen

Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer

Albumin-bound paclitaxel in solid tumors: clinical development and future directions

Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells

Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies

Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel

Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery

Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells

Medikamentenbeschichtete Ballons bei PAVK

Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics

nab-Paclitaxel mechanisms of action and delivery

Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)–paclitaxel nanoconjugates

Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment

Albumin-bound paclitaxel: a next-generation taxane

An Imagable and Photothermal "Abraxane-Like" Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast Tumors

Biodegradable, Hydrogen Peroxide, and Glutathione Dual Responsive Nanoparticles for Potential Programmable Paclitaxel Release

Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo

Paclitaxel: What has been done and the challenges remain ahead

Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus®—Solutol® HS15 binary mixed micelles system

Phase II study of nab‐paclitaxel + carboplatin for patients with non‐small‐cell lung cancer and interstitial lung disease

NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform

Aktive Filter

Suchergebnisse filtern